Search

The article focuses on a pilot study that suggests vaginal microbiota transfer (VMT) may positively impact the neurodevelopment of infants born via cesarean delivery. The study found that VMT in cesarean-delivered infants led to higher neurodevelopment scores compared to a control group, indicating the potential for VMT to improve the fecal microbiome and neurodevelopment in cesarean-born infants. Further studies are needed to explore the long-term effects and clinical implications of VMT.

The article discusses the need for a deeper understanding of the mechanisms underlying the success of fecal microbiota transplantation (FMT) to enhance its effectiveness in treating various diseases. Topics include factors influencing FMT's success; engraftment of donor microbial strains; personalized donor-recipient pairings; the possible role of viruses and fungi in FMT; importance of repeat treatments for sustained response; and expansion of FMT beyond Clostridium difficile infections.

Reports on the potential health applications of probiotics. Research on probiotics as an answer to antibiotic resistance and abuse; Absence of bacteria in the intestines and susceptibility of infants to allergies and life-threatening infections; Review of the ability of probiotics to prevent premature labor and delivery arising from bacterial vaginosis; Proliferation of untested probiotic products in the United States.

The article discusses research that examined the efficacy of a synthetic biology-based treatment for phenylketonuria (PKU). Topics covered include the use of engineered bacteria to break down a naturally occurring toxin in the blood, the traditional treatment for PKU, and Synlogic's clinical testing of the synthetic biology-based treatment.

The article focuses on the potential of a compound produced by a nose-dwelling bacterium in the development of medicines to fight epidemic of drug resistance.

The article offers information related to the research done by University of British Columbia, Canada, which discovered the genetic machinery that turns a common human gut bacterium to metabolise a main component of dietary fibre from the cell walls of fruit and vegetables.

The article features the delay of the field tests of genetically altered bacteria by researchers at the University of California at Berkeley due to local opposition. Steven E. Lindow, an associate professor of plant pathology at Berkeley, won federal approval last month for field tests of the bacteria, which were designed to protect potato plants from frost. The tests had been blocked for two years by a lawsuit and a federal court order.